David Moore to Anti-HIV Agents
This is a "connection" page, showing publications David Moore has written about Anti-HIV Agents.
Connection Strength
2,269
-
Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Clin Infect Dis. 2018 05 02; 66(10):1566-1572.
Score: 0,321
-
Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS Behav. 2015 Mar; 19(3):459-71.
Score: 0,258
-
Results from a Pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender Women in the United States. Clin Infect Dis. 2021 10 05; 73(7):1149-1156.
Score: 0,102
-
Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV. J Neurovirol. 2021 02; 27(1):160-167.
Score: 0,097
-
Antiretroviral drug concentrations in brain tissue of adult decedents. AIDS. 2020 11 01; 34(13):1907-1914.
Score: 0,095
-
Tailoring a mobile health text-messaging intervention to promote antiretroviral therapy adherence among African Americans: A qualitative study. PLoS One. 2020; 15(6):e0233217.
Score: 0,093
-
Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 12 01; 33(15):2309-2316.
Score: 0,090
-
Characteristics of a cohort of high-risk men who have sex with men on pre-exposure prophylaxis reporting transgender sexual partners. Medicine (Baltimore). 2019 Dec; 98(50):e18232.
Score: 0,090
-
The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease. J Neurovirol. 2019 10; 25(5):661-672.
Score: 0,084
-
Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV. J Acquir Immune Defic Syndr. 2019 01 01; 80(1):e9-e13.
Score: 0,084
-
Patient Responses on Quality of Care and Satisfaction with Staff After Integrated HIV Care in South African Primary Health Care Clinics. J Assoc Nurses AIDS Care. 2018 Sep - Oct; 29(5):698-711.
Score: 0,080
-
Measures of Physical and Mental Independence Among HIV-Positive Individuals: Impact of Substance Use Disorder. AIDS Res Hum Retroviruses. 2017 Oct; 33(10):1048-1055.
Score: 0,075
-
Can research at the end of life be a useful tool to advance HIV cure? AIDS. 2017 01 02; 31(1):1-4.
Score: 0,073
-
Efavirenz as a cause of ataxia in children. S Afr Med J. 2015 Nov; 105(11):897-8.
Score: 0,067
-
Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users. AIDS Care. 2014; 26(12):1477-81.
Score: 0,061
-
HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS. 2014 Jun 01; 28(9):1297-306.
Score: 0,061
-
Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology. 2013 Jan 22; 80(4):371-9.
Score: 0,056
-
Changes in pediatric HIV-related hospital admissions and mortality in Soweto, South Africa, 1996-2011: light at the end of the tunnel? J Acquir Immune Defic Syndr. 2012 Aug 15; 60(5):503-10.
Score: 0,054
-
Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder. AIDS Patient Care STDS. 2012 Jul; 26(7):388-94.
Score: 0,053
-
Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis. 2012 May; 54(10):1485-94.
Score: 0,053
-
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/µL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis. 2012 Apr; 54(8):1204-11.
Score: 0,052
-
Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses. 2012 Jan; 28(1):95-9.
Score: 0,049
-
Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One. 2009; 4(1):e4149.
Score: 0,042
-
Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda. AIDS Patient Care STDS. 2008 Oct; 22(10):787-95.
Score: 0,041
-
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet. 2008 Mar 01; 371(9614):752-9.
Score: 0,040
-
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl. AIDS. 2006 May 12; 20(8):1117-23.
Score: 0,035
-
Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances. J Neurovirol. 2020 12; 26(6):888-898.
Score: 0,023
-
'People say that we are already dead much as we can still walk': a qualitative investigation of community and couples' understanding of HIV serodiscordance in rural Uganda. BMC Infect Dis. 2016 11 10; 16(1):665.
Score: 0,018
-
Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2010 Jan; 53(1):28-35.
Score: 0,011
-
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr. 2008 Mar 01; 47(3):304-11.
Score: 0,010